Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Tuberculosis infection prevention and control: why we need a whole systems approach.
Kielmann, K; KARAT, AS; Zwama, G; Colvin, C; Swartz, A; Voce, AS; Yates, TA; MacGregor, H; MCCREESH, N; Kallon, I; VASSALL, A; GOVENDER, I; SEELEY, J; GRANT, AD;
2020
Infectious diseases of poverty, (2020).9 1 10.1186/s40249-020-00667-6.
Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review.
Tan, C; Kallon, II; Colvin, CJ; GRANT, AD;
2020
PloS one, (2020).15 10 10.1371/journal.pone.0241039.
Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.
Cunnama, L; Gomez, GB; Siapka, M; Herzel, B; Hill, J; Kairu, A; Levin, C; Okello, D; DeCormier Plosky, W; Garcia Baena, I; SWEENEY, S; VASSALL, A; Sinanovic, E;
2020
PHARMACOECONOMICS, (2020).38 8 10.1007/s40273-020-00928-0.
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
Penn-Nicholson, A; Mbandi, SK; Thompson, E; Mendelsohn, SC; Suliman, S; Chegou, NN; Malherbe, ST; Darboe, F; Erasmus, M; Hanekom, WA; Bilek, N; Fisher, M; Kaufmann, SH E; Winter, J; Murphy, M; Wood, R; Morrow, C; Van Rhijn, I; Moody, B; Murray, M; Andrade, BB; Sterling, TR; SUTHERLAND, J; Naidoo, K; Padayatchi, N; ... CAPRISA IMPRESS team,
2020
Scientific reports, (2020).10 1 10.1038/s41598-020-65043-8.
Knowledge, attitude and practice towards tuberculosis in Gambia: a nation-wide cross-sectional survey.
BASHORUN, AO; Linda, C; Omoleke, S; Kendall, L; Donkor, SD; Kinteh, M-A; Danso, B; Leigh, L; Kandeh, S; D'ALESSANDRO, U; ADETIFA, IM O;
2020
BMC Public Health, (2020).20 1 10.1186/s12889-020-09685-3.
Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection.
Kewcharoenwong, C; Saenwongsa, W; WILLCOCKS, SJ; BANCROFT, GJ; FLETCHER, HA; Lertmemongkolchai, G;
2020
Tuberculosis (Edinburgh, Scotland), (2020).123, 10.1016/j.tube.2020.101939.
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.
TOGUN, T; KAMPMANN, B; Stoker, NG; Lipman, M;
2020
Annals of clinical microbiology and antimicrobials, (2020).19 1 10.1186/s12941-020-00363-1.
Small-area level socio-economic deprivation and tuberculosis rates in England: An ecological analysis of tuberculosis notifications between 2008 and 2012.
NGUIPDOP-DJOMO, P; RODRIGUES, LC; Abubakar, I; MANGTANI, P;
2020
PLOS ONE, (2020).15 10 10.1371/journal.pone.0240879.
The association between chronic kidney disease and tuberculosis; a comparative cohort study in England.
Ruzangi, J; Iwagami, M; SMEETH, L; MANGTANI, P; NITSCH, D;
2020
BMC NEPHROLOGY, (2020).21 1 10.1186/s12882-020-02065-4.
Modelling of the Epidemiological Impact, Cost-effectiveness and Budget Impact of Novel Tuberculosis Vaccines on Multidrug-resistant Tuberculosis in China.
WEERASURIYA, C; Harris, R; Gomez, GB; WHITE, R;
2020
(2020).